Serum cysteine proteases and their inhibitors in rheumatoid arthritis: Relation to disease activity and radiographic progression

Clinical Rheumatology

Volumn 30, Issue 5, 2011, Pages 633-638

  Jørgensen, Iben ^a   Kos, Janko ^b,c   Krašovec, Marta ^b,c   Troelsen, Lone ^a   Klarlund, Mette ^d   Jensen, Trine W ^e   Hansen, Michael S ^e   Jacobsen, Søren ^a   Florescu, Adrian ^f   Hørslev Petersen, Kim ^f   Pødenphant, Jan ^f   Stoltenberg, Michael ^f   Hetland, Merete Lund ^f   Johansen, Julia Sidenius ^f   Lorenzen, Ib ^f   Skjødt, Henrik ^f   Østergaard, Mikkel ^f  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f Rigshospitalet ^*

Author keywords

Erosive disease; Proteases; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN H; CYSTATIN C; STEFIN A; STEFIN B;

ARTICLE; BONE EROSION; CHRONIC ARTHRITIS; DISEASE ACTIVITY; DISEASE COURSE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HAND; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT RADIOGRAPHY; LARSEN SCORE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; WRIST;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CATHEPSIN B; CATHEPSIN H; CHRONIC DISEASE; COHORT STUDIES; CYSTATIN A; CYSTATIN B; CYSTATIN C; CYSTEINE PROTEASES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED;

EID: 79959691939     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1585-1     Document Type: Article

References (24)

1. Cunnane G, Fitzgerald O, Hummel KM, Gay RE, Gay S et al (1999) Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 38:34-42
2. Cunnane G, Fitzgerald O, Hummel KM, Youssef PP, Gay RE et al (2001) Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 44:1744-1753
3. Hansen T, Petrow PK, Gaumann A, Keyzer GM, Eysel P et al (2000) Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium. J Rheumatol 27(4):859-865
4. Trabant A, Gay RE, Fassbender HG, Gay S (1991) Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 34:1444-1451
5. Solau-Gervais E, Zerimech F, Lemaire R, Fontaine C, Huet G, Flipo RM (2007) Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 36:373-737
6. Keyszer G, Lambiri I, Keysser M, Keysser C, Nagel R et al (1998) Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity. Z Rheumatol 57:392-398
7. Biroc SL, Gay S, Hummel K, Magill C, Palmer JT et al (2001) Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor. Arthritis Rheum 44:703-711
8. Keyszer G, Redlich A, Haupl T, Zacher J, Sparmann M et al (1998) Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 41:1378-1387
9. Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncol Rep 5:1349-1361
10. Finckh A, Simard JF, Duryea J, Liang MH, Huang J, Daneel S, Forster A, Gabay C, Guerne PA (2006) The effectiveness of antitumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. Arthritis Rheum 54:54-59
11. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
12. Hansen M, Florescu A, Stoltenberg M, Pødenphant J, Pedersen-Zbinden B, Hørslev-Petersen K, Hyldstrup L, Lorenzen I (1996) Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment. Scand J Rheumatol 25:367-376
13. Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjødt H, Jensen KE, Svejgaard A, Garred P, TIRA Group (2001) The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. J Rheumatol 28:935-942
14. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 18:481-491
15. Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, Vrhovec I, Cathepsin V (1997) H and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 3:1815-1822
16. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N (2000) Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 6:505-511
17. Solau-Gervaise ZF, Lemaire R, Fontaine C, Huet G, Flipo RM (2007) Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 36:373-377
18. Hashimoto Y, Kakegawa H, Narita Y, Hachiya Y, Hayakawa T, Kos J, Turk V, Katunuma N (2001) Medical significance of specific accumulation of cathepsin B in synovial fluid of patients with rheumatoid arthritis. Biol Chem Res Commun 283:334-339
19. Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk Wet al (2005) Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction. Arthritis Res Ther 7:R65-R70
20. Bokarewa M, Abrahamson M, Levshin N, Egesten A, Grubb A, Dahlberg L, Tarkowski A (2007) Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties. J Rheumatol 34:1293-1301
21. Gunatilleke SS, de Oliveira CA, McCammon JA, Barrios AM (2008) Inhbition of cathepsin B by Au(I) complexes: a kinetic and computational study. J Biol Inorg Chem 13:555-561
22. Abisi S, Burnand KG, Humphries J, Waltham M, Taylor P, Smith A (2008) Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms. Br J Surg 95:333-337
23. Esser RE, Watts LM, Angelo RA, Thornburg LP, Prior JJ et al (1993) The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis. J Rheumatol 207:1176-1183
24. Svelander L, Erlandsson-Harris H, Astner L, Grabowska U, Klareskog L, Lindstrom E, Hewitt E (2009) Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice. Eur J Pharmacol 24:155-162